Evidence map›Paper›PMID 34946571›Full record

ArticleMolecules (Basel, Switzerland)2021

HIV-1 Tat and Heparan Sulfate Proteoglycans Orchestrate the Setup of

Chiara Urbinati, Maria Milanesi, Nicola Lauro, Cinzia Bertelli, Guido David, Pasqualina D'Ursi, Marco Rusnati, Paola Chiodelli

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Chiara UrbinatiExperimental Oncology and Immunology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Maria MilanesiExperimental Oncology and Immunology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.ORCID 0000-0002-1902-1544
Nicola LauroExperimental Oncology and Immunology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
Cinzia BertelliDepartment of Cellular, Computational and Integrative Biology, University of Trento, 38123 Trento, Italy.ORCID 0000-0002-9443-1957
Guido DavidDepartment of Human Genetics, University of Leuven, B-3000 Leuven, Belgium.
Pasqualina D'UrsiInstitute for Biomedical Technologies, National Research Council (ITB-CNR), 20090 Segrate, Italy.ORCID 0000-0003-1554-429X
Marco RusnatiExperimental Oncology and Immunology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.ORCID 0000-0001-9968-5908
Paola ChiodelliExperimental Oncology and Immunology, Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, Italy.
University of Brescia · ITInstitute of Biomedical Technologies · ITKU Leuven · BEUniversity of Trento · IT

Funding

EU Project EOSC-Pillar 857650EU project EOSC-Pillar and pan-European research infrastructure for Biobanking and Bi-oMolecular Re-sources Research In-frastructure BBMRIministero dell'università e ricerca ex 60% to MR
6 · The paper itself

Abstract

HIV-1 transactivating factor Tat is released by infected cells. Extracellular Tat homodimerizes and engages several receptors, including integrins, vascular endothelial growth factor receptor 2 (VEGFR2) and heparan sulfate proteoglycan (HSPG) syndecan-1 expressed on various cells. By means of experimental cell models recapitulating the processes of lymphocyte trans-endothelial migration, here, we demonstrate that upon association with syndecan-1 expressed on lymphocytes, Tat triggers simultaneously the

Indexed as

Cell AdhesionCell MovementEndotheliumHeparan Sulfate ProteoglycansHumansLymphocytesModels, MolecularMolecular StructureStereoisomerismtat Gene Products, Human Immunodeficiency VirusTumor Cells, CulturedHeparan Sulfate Proteoglycanstat Gene Products, Human Immunodeficiency Virusendothelial cellsheparan sulfate proteoglycansHIV-1 Tatintegrinslymphocyte extravasationmolecular modelling docking and dynamicssignal transduction

Identifiers

PMID34946571
PMCPMC8705413
OpenAlexW4200273966

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.